Ignite Creation Date:
2024-05-06 @ 7:31 AM
Last Modification Date:
2024-10-26 @ 11:49 AM
Study NCT ID:
NCT02549911
Status:
UNKNOWN
Last Update Posted:
2015-09-15
First Post:
2015-09-07
Brief Title:
HIPEC Intravenous Chemotherapy and Surgery for the Treatment of Advanced GC With Peritoneal Metastasis
Sponsor:
Zhejiang Cancer Hospital
Organization:
Zhejiang Cancer Hospital
Study Overview
Official Title:
Hyperthermic Intraperitoneal Chemotherapy Intravenous Chemotherapy Combined With Surgery for the Treatment of Advanced Gastric Cancer With Peritoneal Metastasis
Status:
UNKNOWN
Status Verified Date:
2015-09
Last Known Status:
RECRUITING
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Explore the hyperthermic intraperitoneal chemotherapy HIPEC and intravenous chemotherapy for Creating the Operation Chance in advanced gastric cancer with peritoneal metastasis
Detailed Description:
To assess the effectiveness and safety of Hyperthermic intraperitoneal chemotherapy intravenous chemotherapy combined with surgery for the treatment of advanced gastric cancer with peritoneal metastasisso as to further find out the optimal protocol for the Conversion therapy in the patients with advanced gastric cancer
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None